FDA Drug recall D-065-2013
Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKl…
- FDA Drug
- Class III
- terminated
- Published 2012-12-05
On 2012-12-05 the FDA classified a Class III recall of Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKl… by Glaxosmithkline, citing product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-065-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2012-10-24 |
| Published | 2012-12-05 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Glaxosmithkline |
| Distribution | US |
Product
Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709.
Reason
Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.
Identifiers
| ndc | 0173-0715-20 |
|---|---|
| ndc | 0173-0715-22 |
| ndc | 0173-0716-20 |
| ndc | 0173-0716-22 |
| ndc | 0173-0717-20 |
| ndc | 0173-0717-22 |
| code_info | 1ZP3065, Exp. Oct-12, 1ZP5453, Exp. Dec-12, 1ZP3315, Exp. May-13, 2ZP9974, Exp. Sep-13. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-065-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.